158.36
6.02%
-10.14
Dopo l'orario di chiusura:
159.00
0.64
+0.40%
Precedente Chiudi:
$168.50
Aprire:
$168.92
Volume 24 ore:
2.23M
Relative Volume:
1.84
Capitalizzazione di mercato:
$19.45B
Reddito:
$1.53B
Utile/perdita netta:
$-214.69M
Rapporto P/E:
-89.98
EPS:
-1.76
Flusso di cassa netto:
$-43.68M
1 W Prestazione:
-9.51%
1M Prestazione:
-5.86%
6M Prestazione:
+43.48%
1 anno Prestazione:
+134.61%
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Confronta NTRA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
NTRA
Natera Inc
|
158.36 | 19.45B | 1.53B | -214.69M | -43.68M | -1.76 |
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-06-03 | Ripresa | Jefferies | Buy |
2024-04-08 | Ripresa | Craig Hallum | Buy |
2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
2023-12-29 | Reiterato | BTIG Research | Buy |
2023-12-14 | Iniziato | Guggenheim | Buy |
2023-12-13 | Iniziato | Wolfe Research | Outperform |
2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2023-09-28 | Iniziato | Bernstein | Mkt Perform |
2023-07-05 | Ripresa | JP Morgan | Overweight |
2023-05-05 | Iniziato | UBS | Buy |
2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2022-08-25 | Iniziato | Credit Suisse | Outperform |
2022-04-25 | Iniziato | Stephens | Overweight |
2022-03-08 | Iniziato | Goldman | Buy |
2022-01-06 | Ripresa | Piper Sandler | Overweight |
2021-10-15 | Ripresa | Cowen | Outperform |
2021-06-15 | Iniziato | Raymond James | Mkt Perform |
2021-05-25 | Iniziato | Wells Fargo | Overweight |
2021-01-28 | Iniziato | Truist | Buy |
2020-10-08 | Iniziato | BTIG Research | Buy |
2020-09-28 | Iniziato | Morgan Stanley | Overweight |
2020-09-17 | Iniziato | SVB Leerink | Outperform |
2020-06-10 | Ripresa | Piper Sandler | Overweight |
2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
2018-10-05 | Iniziato | JP Morgan | Neutral |
2018-07-05 | Reiterato | Piper Jaffray | Overweight |
2017-08-07 | Reiterato | Morgan Stanley | Overweight |
2016-11-10 | Reiterato | The Benchmark Company | Buy |
2016-05-23 | Reiterato | The Benchmark Company | Buy |
2016-05-11 | Reiterato | The Benchmark Company | Buy |
2016-04-19 | Iniziato | The Benchmark Company | Buy |
2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2015-08-04 | Iniziato | Robert W. Baird | Outperform |
2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
2015-07-27 | Iniziato | Piper Jaffray | Overweight |
2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Sheena Jonathan Natera Stock Sale Highlights Insider Confidence Amid Legal and Financial Milestones - HPBL
Looking Into Natera's Recent Short Interest - Benzinga
Artemis Investment Management LLP Sells 135,994 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Avanza Fonder AB Takes $1.02 Million Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera (NASDAQ:NTRA) Shares Down 2.8%Here's Why - MarketBeat
Natera guides Q4 and FY revenue above consensus - MSN
Natera (NASDAQ:NTRA) Price Target Raised to $200.00 at Guggenheim - MarketBeat
Wall Street Analysts Adjust Price Targets: Key Changes for Morgan Stanley, Bank of America, Natera and More - HPBL
Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year - BioSpace
Natera CEO Steve Chapman Named BioTech Innovator of the Year, Leads 20 Product Launches - StockTitan
Analysts reset Natera stock price target by 20% - TheStreet
Rockingstone Advisors LLC Buys Shares of 16,326 Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Assenagon Asset Management S.A. Has $51.47 Million Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera’s Bold Moves Stir Up Stock Market Buzz - TipRanks
Natera reports on robust product pipeline at JPM - BioWorld Online
Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection - BioSpace
Natera Unveils Revolutionary Cancer Detection Tech with 92% Early-Stage Accuracy - StockTitan
Natera (NASDAQ:NTRA) Reaches New 12-Month HighTime to Buy? - MarketBeat
Natera (NASDAQ:NTRA) Shares Gap Up After Analyst Upgrade - MarketBeat
Why Natera Stocks Are Gaining Attention - TipRanks
Non-Invasive Prenatal Testing Market Top Companies Study - openPR
Natera Shatters Growth Records: Q4 Revenue Surges 52% to $472M, Oncology Tests Jump 55% - StockTitan
Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024 - Business Wire
Insider Sell Alert: Daniel Rabinowitz Sells 6,223 Shares of Nate - GuruFocus.com
Harbor Capital Advisors Inc. Trims Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera's chief legal officer sells $1.09 million in stock - Investing.com India
Natera’s chief legal officer sells $1.09 million in stock By Investing.com - Investing.com Nigeria
The Analyst Verdict: Natera In The Eyes Of 14 Experts - Benzinga
Sanford C. Bernstein Issues Positive Forecast for Natera (NASDAQ:NTRA) Stock Price - MarketBeat
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings - The Motley Fool
Natera, Inc. (NASDAQ:NTRA) Shares Sold by First Hawaiian Bank - MarketBeat
Natera Stock Soars to All-Time High of $175.68 By Investing.com - Investing.com Nigeria
Natera (NASDAQ:NTRA) Reaches New 1-Year HighShould You Buy? - MarketBeat
Natera Stock Soars to All-Time High of $175.68 - Investing.com India
Natera nabs ADLT status - LabPulse
Ravgen wins $57M in patent infringement suit against Natera - LabPulse
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Natera to Present at J.P. Morgan Healthcare Conference 2025: Key Investor Updates Coming - StockTitan
3,984 Shares in Natera, Inc. (NASDAQ:NTRA) Purchased by Silverleafe Capital Partners LLC - MarketBeat
Natera Fails to Expand $96 Million Patent Win Over CareDx (1) - Bloomberg Law
(NTRA) Technical Data - Stock Traders Daily
Everence Capital Management Inc. Acquires Shares of 3,620 Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Everence Capital Management Inc. Makes New $573,000 Investment in Natera, Inc. (NASDAQ:NTRA) - Defense World
Natera co-founder Sheena Jonathan sells $909k in stock By Investing.com - Investing.com Nigeria
Natera co-founder Sheena Jonathan sells $909k in stock - Investing.com
Natera Loses New Trial Bid After Winning $96M Patent Verdict - Law360
Undercovered Dozen: Natera, Lloyds Banking Group, Eaton, Primoris Services + - Seeking Alpha
Canaccord Genuity Group Forecasts Strong Price Appreciation for Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera's (NASDAQ:NTRA) investors will be pleased with their enviable 353% return over the last five years - Yahoo Finance
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):